NASDAQ Biotechnology Total Retu XNBI Index
4598.99 USD
{{ price }}
0.187158%
{{change_pct}}%
COUNTRY
United States
Exchange
Nasdaq GIDS
LOW - HIGH [24H]
4576.85
-
4611.78 USD
Number of components
190
NASDAQ Biotechnology Total Retu Price Chart
Top 5 Gainers in the Last 24 Hours
| XBIT | XBiotech | +7.89% | |
|---|---|---|---|
| DBVT | DBV | +6.72% | |
| PACB | Pacific Biosciences of California | +5.74% | |
| INCY | Incyte | +4.83% | |
| VNDA | Vanda Pharmaceuticals | +4.56% |
Top 5 Losers in the Last 24 Hours
| EGRX | Eagle Pharmaceuticals | -17.56% | |
|---|---|---|---|
| FGEN | FibroGen | -7.18% | |
| TRVN | Trevena | -5.61% | |
| OMER | Omeros | -5.14% | |
| SGMO | Sangamo Therapeutics | -4.24% |
NASDAQ Biotechnology Total Retu XNBI Financial and Trading Overview
| NASDAQ Biotechnology Total Retu Index Price | 4598.99 USD |
| Previous Close | 4472.96 USD |
| Open | 4476.26 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 4464.53 - 4532.84 USD |
| 52 Week Range | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Avg. Volume | N/A |
Trading Information
NASDAQ Biotechnology Total Retu Index Price History
| 52 Week High | 4532.84 USD |
| 52 Week Low | 4464.53 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
XNBI Index Statistics
| Avg. Volume (3 months) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
Q&A For NASDAQ Biotechnology Total Retu Index
What is a current XNBI Index price?
NASDAQ Biotechnology Total Retu XNBI Index price today per is 4598.99 USD.
How to purchase NASDAQ Biotechnology Total Retu Index?
You can buy XNBI index on the Nasdaq GIDS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NASDAQ Biotechnology Total Retu?
The Index symbol or ticker of NASDAQ Biotechnology Total Retu is XNBI.
How many components does the NASDAQ Biotechnology Total Retu index contain?
NASDAQ Biotechnology Total Retu index contain 190 components.
What country does the NASDAQ Biotechnology Total Retu index belong to?
NASDAQ Biotechnology Total Retu index refers to the United States.
What exchange does the NASDAQ Biotechnology Total Retu index belong to?
NASDAQ Biotechnology Total Retu index refers to the Nasdaq GIDS.
NASDAQ Biotechnology Total Retu INDEX Companies List - STOCKS & COMPONENTS
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $279.11 — |
-0.44
|
$150.75B — | $2.99M — | $277.75 — | $286.17 — | $150.75B — | 25.44 | $10.97 — |
| Gilead Sciences GILD | $107.62 — |
+1.6
|
$133.87B — | $6.3M — | $105.79 — | $107.86 — | $133.87B — | 22.60 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $443.4 — |
-0.54
|
$114.49B — | $1.17M — | $441.13 — | $446.18 — | $114.49B — | 0 | -$3.81 — |
| Regeneron Pharmaceuticals REGN | $521 — |
+0.14
|
$56.17B — | $964.85K — | $514.79 — | $524.52 — | $56.17B — | 13.24 | $39.34 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $318.25 — |
-1.15
|
$41.98B — | $663.9K — | $315 — | $325 — | $41.98B — | 0 | -$2.1 — |
| Insmed Incorporated INSM | $101.74 — |
-2.97
|
$19.92B — | $3.95M — | $101.14 — | $105.8 — | $19.92B — | 0 | -$5.93 — |
| Biogen BIIB | $126.92 — |
-0.31
|
$18.65B — | $862.17K — | $126.46 — | $129.1 — | $18.65B — | 12.54 | $10.12 — |
| Illumina ILMN | $94.16 — |
+1
|
$14.91B — | $2.93M — | $92.76 — | $95.99 — | $14.91B — | 0 | -$6.08 — |
| Incyte INCY | $70.81 — |
+4.83
|
$13.71B — | $3.02M — | $69.84 — | $71.5 — | $13.71B — | 354.05 | $0.2 — |
| United Therapeutics UTHR | $284.09 — |
-0.66
|
$12.81B — | $357.51K — | $283.52 — | $288.99 — | $12.81B — | 11.31 | $25.11 — |
| Neurocrine Biosciences NBIX | $126.71 — |
-0.84
|
$12.65B — | $476.36K — | $126.2 — | $128.66 — | $12.65B — | 42.95 | $2.95 — |
| Exelixis EXEL | $43.09 — |
-1.01
|
$11.87B — | $2.68M — | $42.66 — | $43.87 — | $11.87B — | 19.67 | $2.19 — |
| Qiagen QGEN | $48.04 — |
+1.24
|
$10.4B — | $1.21M — | $47.74 — | $48.36 — | $10.4B — | 111.72 | $0.43 — |
| BioMarin Pharmaceutical BMRN | $54.1 — |
-0.07
|
$10.38B — | $1.42M — | $53.76 — | $54.55 — | $10.38B — | 20.03 | $2.7 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Blueprint Medicines BPMC | $128.15 — |
-0.08
|
$8.29B — | $2.47M — | $128.1 — | $128.31 — | $8.29B — | 0 | -$2.51 — |
| Bio-Techne TECH | $52.8 — |
+1.75
|
$8.28B — | $2.3M — | $50.61 — | $53.41 — | $8.28B — | 63.61 | $0.83 — |
| Grifols, S.A. GRFS | $8.78 — |
+3.17
|
$7.32B — | $430.92K — | $8.67 — | $8.8 — | $7.32B — | 32.51 | $0.27 — |
| Repligen RGEN | $124.21 — |
+0.15
|
$6.98B — | $717.26K — | $121.99 — | $125.54 — | $6.98B — | 0 | -$0.42 — |
- {{ link.label }} {{link}}